Meet the Editor: David P. Lillicrap, MD, FRCPC

(3:31)

An Overview of Gene Therapy with Professor David Lillicrap

(35:58)

David Lillicrap, MD, discusses AAV gene therapy in a canine hemophilia model

(3:30)

Dr. David Lillicrap | Pursuing a Miracle in Modern-Day Medicine | QHS | 5 à 7 Research Talks

(19:4)

#VWDTalk How does understanding genetics help us manage Von Willebrand Disease? |Dr. David Lillicrap

(5:4)

One size does NOT fit all with Professor David Lillicrap, Dr Víctor Jimenez-Yuste and patient

(23:3)

Co-Editor-in-Chief David Lillicrap Discusses the Role of JTH during the COVID-19 Pandemic

(7:50)

What is gene therapy for hemophilia?

(15:10)

30.ES \

(59:56)

Canada’s Artificial Intelligence Revolution - Dr. Joelle Pineau

(1:6:35)

Deepmind AlphaZero - Mastering Games Without Human Knowledge

(42:29)

Which Country Has the Best \u0026 Worst Life Expectancy? Why? - TLDR News

(9:18)

AUKUS: Why Are France and China so Angry About This Pact? - TLDR News

(8:22)

Keynote David Silver NIPS 2017 Deep Reinforcement Learning Symposium AlphaZero

(42:45)

Jason Wei: Scaling Paradigms for Large Language Models

(40:10)

Dr. IV explains high sensitivity C-reactive protein (CRP) blood tests

(3:22)

Which Country is Safest in an APOCALYPSE? - TLDR News

(8:25)

Could Britain End the Monarchy \u0026 Become a Republic? The Queen's Royal Controversy - TLDR News

(11:3)

David Lillicrap: Can We Cure Haemophilia? at SACC 2017

(47:24)

Getting to Know Gene Therapy Terminology and Concepts

(19:28)

#RendezVous2017 - Session 1 - A BRAVE NEW WORLD IN COAGULATION THERAPIES

(2:26)

CHS Rendez-vous 2017 / SESSION 1 - A BRAVE NEW WORLD IN COAGULATION THERAPIES

(21:57)

What are the clinical trial results in hemophilia gene therapy?

(13:54)

Mechanisms of Tolerance: Immune tolerance induction

(29:22)

CHS Rendez-vous 2023 / SESSION 4: GENE THERAPY: MANAGING EXPECTATIONS

(16:12)

New Therapies for Hemophilia: Balancing Caution with Excitement

(31:)

New Developments in Treatment for Bleeding Disorders – Personalized Prophylaxis

(8:11)

CHS Rendez-vous 2023 / SESSION 4: GENE THERAPY: MANAGING EXPECTATIONS

(27:8)

The evolving treatment landscape of hemophilia - Professor Johnny Mahlangu

(17:47)